Global Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2022-2029

  • This report gives an insight into the global biosimilars market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2022-2029. The future growth has been calculated by taking into account the present growth rate and the overall market size. We have also discussed the alternatives that pose a threat to the growth of the market. In, this report we have categorized global biosimilars market into segments that are: By Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, Others); By Manufacturing (In-house Manufacturing, Contract Manufacturing); By Indication (Auto-Immune Disease, Blood Disorder, Diabetes, Oncology, Growth Deficiency, Female Infertility, Others); By Region (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)

    We have also illustrated the vendor landscape and conducted a detailed analysis of the top five global vendors of the global biosimilars market. The report also presents an analysis of the drivers that enable the growth of the market, the key challenges faced by the vendors and the market as a whole, and the upcoming trends that can have an impact on the market.

    Ample Market Research has collected key data related to the global biosimilars market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso and microeconomic indicators in the market. The report is based on in-depth qualitative and quantitative analyses of the global sports medicine market. The qualitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys and vendor briefings. The data gathered as a result of these processes were validated through experts’ opinions.

    Global Biosimilars Market Would Cross USD 42.4 Bn By 2029

    Global biosimilars market report provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for biosimilars solution providers across the Globe. This report on the global biosimilars market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2029. The report provides revenue of global biosimilars for the period 2019-2029, considering 2021 as the base year and 2022-29 as the forecast year. The report also provides the compound annual growth rate (CAGR 21%) of global biosimilars from 2022 to 2029.

    Segmental Analysis of the global biosimilars market Study

    The global biosimilars market study is segmented based on the various parameters by identifying their business activities, geographical presence, key application areas, end-users, etc., The report covers the market share analysis of all the segments from year 2022-2029. From a strategic point of view, the market outlook covers several frameworks including SWOT Analysis, Value Chain Analysis, and Porter’s Five Forces Analysis while also offering an evaluation of the Product/Market Lifecycle.

    Geographical Coverage of the global biosimilars market Study

    For a better understanding of the global biosimilars, the market is segmented into geographies such as the North America (U.S, Canada), Europe (U.K, France, Germany, Russia, Italy, Rest of Europe), Asia Pacific (China, Japan, India, Australia, South-Korea, Rest of APAC), Latin America (Brazil, Mexico, Rest of Latin America), Middle East and Africa (Saudi Arabia, The U.A.E, South Africa, Rest of MEA). The country level analysis in each region is also provided in a very exhaustive manner.

    Company Analysis on the global biosimilars market Study

    In the report, the degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysis sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers and acquisition by leading companies in the market. The major players have been analyzed by using research methodologies for getting insight on global competition. Major key Players are :-

    • Novartis AG

    • Pfizer Inc.

    • Amgen Inc.

    • Coherus Biosciences Inc.

    • Mylan NV (Viatris Inc.)

    • Samsung Bioepis Co. Ltd

    • Pfizer Inc.

    • Eli Lilly & Company

    • Dr. Reddy’s Laboratories

    • Biocad


  • With tables and figures helping analyze worldwide market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content:

    1. Introduction
    1.1. Research Objective
    1.2. Research Methodology
    1.3. Research Process
    1.4. Respondent Profile

    2. Executive Summary

    3. Global Biosimilars Market Outlook, 2019-2029F
    3.1. Market Size & Analysis
    3.2. Market Share & Analysis
    3.2.1. By Molecule Infliximab Insulin Glargine Epoetin Alfa Etanercept Filgrastim Somatropin Rituximab Follitropin Alfa Adalimumab Pegfilgrastim Trastuzumab Bevacizumab Others
    3.2.2. By Indication Auto-Immune Disease Blood Disorder Diabetes Oncology Growth Deficiency Female Infertility Others
    3.2.3. By Manufacturing In-house Manufacturing Contract Manufacturing
    3.2.4. By Region Asia-Pacific Europe North America Middle East & Africa Latin America

    4. Asia-Pacific Biosimilars Market Outlook, 2019-2029F
    4.1. Market Size & Analysis
    4.2. Market Share & Analysis
    4.2.1. By Molecule
    4.2.2. By Indication
    4.2.3. By Manufacturing
    4.2.4. By Country China India Japan South Korea Australia Rest of Asia-Pacific

    5. Europe Biosimilars Market Outlook, 2019-2029F
    5.1. Market Size & Analysis
    5.2. Market Share & Analysis
    5.2.1. By Molecule
    5.2.2. By Indication
    5.2.3. By Manufacturing
    5.2.4. By Country United Kingdom Germany France Italy Russia Rest of Europe

    6. North America Biosimilars Market Outlook, 2019-2029F
    6.1. Market Size & Analysis
    6.2. Market Share & Analysis
    6.2.1. By Molecule
    6.2.2. By Indication
    6.2.3. By Manufacturing
    6.2.4. By Country United States Canada

    7. Latin America Biosimilars Market Outlook, 2019-2029F
    7.1. Market Size & Analysis
    7.2. Market Share & Analysis
    7.2.1. By Molecule
    7.2.2. By Indication
    7.2.3. By Manufacturing
    7.2.4. By Company Brazil Mexico Rest of Latin America

    8. Middle East & Africa Biosimilars Market Outlook, 2019-2029F
    8.1. Market Size & Analysis
    8.2. Market Share & Analysis
    8.2.1. By Molecule
    8.2.2. By Indication
    8.2.3. By Manufacturing
    8.2.4. By Company Saudi Arabia UAE South Africa Rest of Middle East and Africa

    9. Global Biosimilars Market Dynamics
    9.1. Growth Drivers
    9.2. Challenges
    9.3. Impact Analysis

    10. Global Biosimilars Market Opportunities

    11. Global Biosimilars Value Chain Analysis

    12. Global Biosimilars Market Policies and Regulations

    13. Global Biosimilars Market Trends & Insights

    15. Global Biosimilars Market Porter's Five Forces Analysis

    15. Global Biosimilars Market-Entropy
    15.1. New Product Launches
    15.2. M&A, Collaborations, JVs, and Partnerships

    16. Global Biosimilars Market Company Analysis
    16.1. Novartis AG
    16.2. Pfizer Inc.
    16.3. Amgen Inc.
    16.5. Coherus Biosciences Inc.
    16.5. Mylan NV (Viatris Inc.)
    16.6. Samsung Bioepis Co. Ltd
    16.7. Pfizer Inc.
    16.8. Eli Lilly & Company
    16.9. Dr. Reddy’s Laboratories
    16.10. Biocad

    17. About Us & Contact Details


  • The Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
Licensing options

Need assistance ?

Research objectives

Where will all these developments take the industry in the long

To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

What are the future opportunities in the market?

To understand the structure of Market by identifying its various subsegments.

What are the major driving forces expected to impact the development of the market market across different regions?

To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

To project the consumption of market submarkets, with respect to key regions.

Who are the major driving forces expected to decide the fate of the industry worldwide.

To strategically profile the key players and comprehensively analyze their growth strategies.

What are the key barriers and threats believed to hinder the development of the industry?

To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

Who are the prominent market players making a mark in the market with their winning strategies?

To share detailed information about the key factors influencing the growth of the market

What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Our Clients